Open Access
Issue
Med Buccale Chir Buccale
Volume 22, Number 2, avril 2016
Page(s) 123 - 129
Section Cas clinique et revue de la littérature / Up-to date review and case report
DOI https://doi.org/10.1051/mbcb/2016017
Published online 25 May 2016
  1. Ejeil AL, Dridi SM. Ulcération unique: démarche diagnostique. Rev Odont Stomat 2011;40:305-311. [Google Scholar]
  2. Scully C, Bagan JV. Adverse drug reactions in the orofacial region. Crit Rev Oral Biol Med 2004;15:221-239. [CrossRef] [PubMed] [Google Scholar]
  3. Madinier I, Berry N, Chichmanian RM. [Drug-induced oral ulcerations]. Les ulcérations orales d’origine médicamenteuse. Ann Med Interne 2000;151:248-254. [Google Scholar]
  4. Sibaud V, Boralevi F, Vigarios E, Fricain JC. Oral toxicity of targeted anticancer therapies. Ann Dermatol Venereol 2014;141: 354-363. [CrossRef] [PubMed] [Google Scholar]
  5. Frampton J, Buckley MM, Fitton A. Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectoris. Drugs 1992;44:625-655. [Google Scholar]
  6. Boulinguez S, Bedane C, Bouyssou-Gauthier ML, Cornée-Leplat I, Truong E, Bonnetblanc JM. Giant buccal aphthosis caused by nicorandil. Presse Med 1997;26:558. [Google Scholar]
  7. Reichert S, Antunes A, Trechot P, Barbaud A, Weber M, Schmutz JL. Major aphthous stomatitis induced by nicorandil. Eur J Dermatol 1997;7:132-133. [Google Scholar]
  8. Agbo-Godeau S, Joly P, Lauret Ph, Szpirglas R, Szpirglas H. Association of major apthous ulcers and nicorandil. The Lancet 1998; 352:1598-1599. [CrossRef] [Google Scholar]
  9. Roussel S, Courville P, Peron JM, Delcampe P, Metayer J. Oral aphthae induced by nicorandil. Anatomopathologic aspects. Apropos of a case. Rev Stomatol Chir Maxillofac 1998;99:207-209. [Google Scholar]
  10. Desruelles F, Bahadoran P, Lacour JP, Perrin C, Santini J, Ortonne JP. Giant oral aphthous ulcer induced by nicorandil. Br J Dermatol 1998; 138:712-713. [CrossRef] [PubMed] [Google Scholar]
  11. Marquart-Elbaz C, Lipsker D, Grosshans E, Cribier B. Oral ulcers induced by nicorandil: prevalence and clinicopathological aspects]. Ulcérations buccales induites par le nicorandil: prévalence et aspects clinicopathologiques. Ann Dermatol Venereol 1999;126:587-590. [Google Scholar]
  12. Healy CM, Smyth Y, Flint CR. Persistent nicorandil induced oral ulceration. Heart 2004;90:e38. [CrossRef] [PubMed] [Google Scholar]
  13. Yamamoto K, Matsusue Y, Horita S, Minamiguchi M, Komatsu Y, Kirita T. Nicorandil-induced oral ulceration: report of 3 cases and review of the Japanese literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2011;112:754-759. [CrossRef] [PubMed] [Google Scholar]
  14. Gupta A, Moris G. Major apthous ulcers induced by nicorandil. Age Aging 2000; 29:372-373. [CrossRef] [Google Scholar]
  15. Webster K, Godbold P. Nicorandil induced oral ulceration. Br Dent J 2005;198:619-621. [CrossRef] [PubMed] [Google Scholar]
  16. Jang HS, Jo JH, Kim BS, Jun GJ, Lee JB, Kim MB et al. A case of severe tongue ulceration and laryngeal inflammation induced by low-dose nicorandil therapy. Br J Dermatol 2004;151:939-941. [CrossRef] [PubMed] [Google Scholar]
  17. Boulinguez S, Sommet A, Bedane C, Viraben R, Bonnetblanc JM. Oral nicorandil-induced lesions are not aphthous ulcers. J Oral Pathol Med 2003;32:482-485. [CrossRef] [PubMed] [Google Scholar]
  18. Laveau F, Chapuis H, Dandurand M, Guillot B. Ulcère éosinophilique lingual. Ann Dermatol Venereol 2000;127:716-718. [PubMed] [Google Scholar]
  19. Ficarra G, Prignano F, Romagnoli P. Traumatic eosinophilic granuloma of oral mucosa: A CD30+ lymphoproliferative disorder? Oral Oncol 1997;33:375-379. [CrossRef] [PubMed] [Google Scholar]
  20. Hirshberg A, Amariglio N, Akrish S, Yahalom R, Rosenbaum H, Okon E, et al. Traumatic ulcerative granuloma with stromal eosinophilia: A reactive lesion of the oral mucosa. Am J Clin Pathol 2006;126:522-529. [CrossRef] [PubMed] [Google Scholar]
  21. Trechot P, Jouzeau JY, Brouillard C, Scala-Bertola J, Petitpain N, Cuny JF, et al. Role of nicotinic acid and nicotinamide in nicorandil-induced ulcerations: from hypothesis to demonstration. Int Wound J 2015;12:527-530. [CrossRef] [PubMed] [Google Scholar]
  22. Lee CC, Chang SS, Lee SH, Chen YS, Hsu WT, Gabriel Lee MT. Use of nicorandil is Associated with Increased Risk for Gastrointestinal Ulceration and Perforation- A Nationally Representative Population-based study. Sci Rep 2015;5:11495. [CrossRef] [PubMed] [Google Scholar]
  23. Colvin HS, Barakat T, Moussa O, Babu H, Slaughter T, Palmer JG, Hinson FL. Nicorandil associated anal ulcers: an estimate of incidence. Ann R Coll Surg Engl 2012;94:170-172. [CrossRef] [PubMed] [Google Scholar]
  24. Fraunfelder FW, Fraunfelder FT. Conjunctival and corneal ulceration associated with nicorandil. Cutan Ocul Toxicol 2014;33:120-121. [CrossRef] [PubMed] [Google Scholar]
  25. Yap T, Philippou P, Perry M, Lam W, Corbishley C, Watkin N. Nicorandil-induced penile ulcerations: a case series. BJU Int 2011;107:268-271. [CrossRef] [PubMed] [Google Scholar]
  26. Lee MG, Lin HY, Lee SH, Lee SH, Chang SS, Chen SC, et al. Risk of skin ulcerations associated with oral nicorandil therapy: a population-based study. Br J Dermatol 2015;173:498-509. [CrossRef] [PubMed] [Google Scholar]
  27. Goh C, Wong SC, Borland C. Persistent orocutaneous and anal fistulae induced by nicorandil: a case report. J Med Case Rep 2009;3:119. [CrossRef] [Google Scholar]
  28. AFSSAPS. Nicorandil et ulcérations graves. Lettre aux professionnels de santé. Mars 2012. [Google Scholar]
  29. Bégaud B, Evreux JC, Jouglard J, Lagier G. [Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France]. Therapie 1985;40:111-118. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.